Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: combined appetite and metabolic mechanisms
Also known as: 5AMQ + Sema
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
This blend combines 5-Amino-1MQ, an NNMT inhibitor studied in animal models for adipocyte and NAD+ metabolism effects, with Semaglutide, a GLP-1 receptor agonist with well-established human clinical evidence for appetite suppression and glycemic control. 5-Amino-1MQ has no published human clinical trials; its weight-related evidence is limited to diet-induced-obese mouse studies. Semaglutide is independently well-studied and covered elsewhere in this catalog. The combination itself has not been evaluated in any published trial.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Derived from individually verified single-compound research profiles; migrated from prior internal compound records, July 2026
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Important evidence gap: 5-Amino-1MQ has zero published human clinical trials for weight/fat loss; its evidence base is limited to diet-induced-obese mouse studies. Semaglutide is independently well-established. Treat any claimed synergy as unverified. The previous combination schedule was not traceable to a controlled study and was removed.
Supplementary research context only. Not medical advice or a treatment recommendation.
Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.
Community discussion of 5-Amino-1MQ generally is mixed: some users report noticeable fat-loss/energy effects, others report supplier-quality concerns or minimal effect; no threads specifically discuss the semaglutide combination, but users commonly mention pairing NNMT inhibitors like 5-Amino-1MQ with GLP-1 therapy for added fat-loss support. Anecdotal, not clinically verified.
User reports a questionable product experience with unusual side effects (heavy urination, pelvic discomfort), with commenters flagging it may indicate an adulterated/mislabeled product rather than a true 5-Amino-1MQ effect.
User reports subjective dose-equivalence comparisons between injectable and oral 5-Amino-1MQ, describing early energy/appetite effects. Single self-reported account, not corroborated by clinical data.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.